GB202409624D0 - Biomarkers of pregnancy loss - Google Patents
Biomarkers of pregnancy lossInfo
- Publication number
- GB202409624D0 GB202409624D0 GBGB2409624.0A GB202409624A GB202409624D0 GB 202409624 D0 GB202409624 D0 GB 202409624D0 GB 202409624 A GB202409624 A GB 202409624A GB 202409624 D0 GB202409624 D0 GB 202409624D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- biomarkers
- pregnancy loss
- pregnancy
- loss
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Biophysics (AREA)
- Gynecology & Obstetrics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2409624.0A GB202409624D0 (en) | 2024-07-03 | 2024-07-03 | Biomarkers of pregnancy loss |
| PCT/EP2025/068823 WO2026008695A1 (en) | 2024-07-03 | 2025-07-02 | Biomarkers of pregnancy loss |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2409624.0A GB202409624D0 (en) | 2024-07-03 | 2024-07-03 | Biomarkers of pregnancy loss |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202409624D0 true GB202409624D0 (en) | 2024-08-14 |
Family
ID=92213517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2409624.0A Pending GB202409624D0 (en) | 2024-07-03 | 2024-07-03 | Biomarkers of pregnancy loss |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB202409624D0 (en) |
| WO (1) | WO2026008695A1 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010010201A1 (en) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Gene expression profile as a marker of endometrial receptivity |
| GB201911947D0 (en) | 2019-08-20 | 2019-10-02 | Univ Warwick | Miscarriage biomarkers |
| CN114292907A (en) * | 2020-12-15 | 2022-04-08 | 苏州亿康医学检验有限公司 | Biomarkers and diagnostic and therapeutic methods for recurrent implantation failure |
| GB202216420D0 (en) * | 2022-11-04 | 2022-12-21 | Univ Warwick | Biomarkers of pregnancy loss |
-
2024
- 2024-07-03 GB GBGB2409624.0A patent/GB202409624D0/en active Pending
-
2025
- 2025-07-02 WO PCT/EP2025/068823 patent/WO2026008695A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2026008695A1 (en) | 2026-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202216420D0 (en) | Biomarkers of pregnancy loss | |
| GB202409624D0 (en) | Biomarkers of pregnancy loss | |
| EP4163384A4 (en) | Method for determining pregnancy status of pregnant woman | |
| GB202509310D0 (en) | Biomarkers | |
| GB202419126D0 (en) | Biomarkers | |
| GB202418087D0 (en) | Biomarkers | |
| GB202413914D0 (en) | Biomarkers | |
| GB202411373D0 (en) | Biomarkers | |
| GB202409296D0 (en) | Biomarkers | |
| GB202403274D0 (en) | Biomarkers | |
| GB202409378D0 (en) | Biomarkers for pre-eclampsia | |
| GB202412594D0 (en) | Cancer biomarkers | |
| CA239494S (en) | Liner-prosthesis interface | |
| GB202508238D0 (en) | Prognosis | |
| GB202510153D0 (en) | Biomarkers and cancer | |
| GB202500386D0 (en) | Agonists | |
| CA233244S (en) | Cooler | |
| GB202406141D0 (en) | Full duplex | |
| CA232700S (en) | Tele-plier | |
| CA232701S (en) | Tele-plier | |
| CA232699S (en) | Tele-plier | |
| CA231635S (en) | Cardprotector | |
| CA230174S (en) | Kettlebell | |
| GB202416244D0 (en) | Prediction of chromatin state | |
| GB202403233D0 (en) | Translation of identifiers |